Powell Investment Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Powell Investment Advisors's PFE Position: Q4 2024 in Review
Powell Investment Advisors sold out of Pfizer (PFE) in Q4 2024, closing a stake of 22,219 shares — an estimated $643K sold.
Powell Investment Advisors first reported a position in PFE in Q4 2019 and held it in 20 quarters. The position peaked at $730K in Q4 2022. 2,995 funds tracked by Wall St. Rank hold PFE as of Q4 2024.
- Powell Investment Advisors reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
- Powell Investment Advisors sold 22,219 Pfizer shares in Q4 2024, an estimated $643K.
- Powell Investment Advisors first reported a position in Pfizer in Q4 2019 and held it in 20 quarters.
- Powell Investment Advisors's Pfizer position peaked at $730K in Q4 2022.
- 2,995 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.
Based on Powell Investment Advisors's 13F filing for Q4 2024, filed 29 Jan 2025.